Patent ID: 11891439
Assignee: ASTUTE MEDICAL, INC.
Field: Measurement (Instruments)
Classification: CPC C  G | IPC C  G

Claim 11:
12. The method of claim 11, wherein
(a) the minimum detectable concentration of CCL14 in the immunoassay is 10 ng/mL or less;
(b) the immunoassay is performed in a lateral flow format;
(c) the immunoassay is an in vitro diagnostic; or
(d) the immunoassay is performed by applying the biological sample to a disposable test device, and the detectable signal is obtained by inserting the disposable test device into an analytical instrument, wherein the sandwich complexes comprising the first and second monoclonal antibodies or antigen binding fragments thereof are immobilized for detection in a predetermined zone of the disposable test device, and wherein the analytical instrument detects the immobilized sandwich complexes to provide the detectable signal.